Contribution of degradation products to the anticancer activity of curcumin

Clinical Cancer Research

Volumn 15, Issue 22, 2009, Pages 7108-

  Shen, Liang ^a   Ji, Hong Fang ^a  

^a SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FERULIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VANILLIN;

ANTINEOPLASTIC ACTIVITY; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG STABILITY; ENZYME INHIBITION; HUMAN; LETTER; PANCREAS CANCER; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CURCUMIN; HUMANS; HYDROGEN-ION CONCENTRATION; NF-KAPPA B; PANCREATIC NEOPLASMS; TEMPERATURE;

EID: 72549092899     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1749     Document Type: Letter

References (5)

1. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008;14:4491-4499
2. Wang YJ, Pan MH, Cheng AL, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997;15:1867-1876
3. Jayaprakasam B, Vanisree M, Zhang Y, et al. Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation. J Agric Food Chem 2006;54:5375-5381 (Pubitemid 44195715)
4. Jung KJ, Go EK, Kim JY, et al. Suppression of age-related renal changes in NF-κB and its target gene expression by dietary ferulate. J Nutr Biochem 2009;20:378-388
5. Murakami Y, Hirata A, Ito S, et al. Re-evaluation of cyclooxygenase-2- inhibiting activity of vanillin and guaiacol in macrophages stimulated with lipopolysaccharide. Anticancer Res 2007;27:801-807 (Pubitemid 46586984)